FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Clinical trial NCT03718923 · RECRUITING

Trial details

NCT number: NCT03718923
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Study type: OBSERVATIONAL

FOXP1 Mental Retardation With Language Impairment and With or Without Autistic Features Autism Spectrum Disorder

Start date: 2016-03-28
Primary completion: 2028-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.